[{"ATTACHMENTNAME":"bfa36dca-488e-485b-a90e-0a6a85f2f066.pdf","NEWS_DT":"2021-11-08T10:53:33.687","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Further to our communication dated 29th October 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 29th October 2021 at 4.45 p.m. has been uploaded on the Company's website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ2(Jul-Sep)2021-22.pdf","SCRIP_CD":532331,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"3abeab2c-7c26-4694-8608-b8fd068f0f49.pdf","NEWS_DT":"2021-08-02T18:48:18.99","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Further to our communication dated 30th July 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 29th July 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ1(Apr-Jun)2021-22.pdf<BR> <BR> This is for your information and records please.","SCRIP_CD":532331,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"47d035f6-30eb-4976-907b-e1936e216dac.pdf","NEWS_DT":"2021-05-04T14:24:30.58","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Further to our communication dated 30th April 2021 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 30th April 2021 at 5.30 p.m. has been uploaded on the Company's website and can be accessed through the link http://ajantapharma.com/Results.aspx<BR> <BR> This is for your information and records please.","SCRIP_CD":532331,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"5bfe024e-353a-4d31-9fc3-7989ed99f58f.pdf","NEWS_DT":"2022-11-10T13:07:44.157","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Further to our communication dated 3rd November 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 3rd November 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link https://ajantapharma.com//images/EarningsCallTranscriptQ2FY23.pdf .","SCRIP_CD":532331,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"694ff1ee-1c91-42d0-aeb1-56e94bb44931.pdf","NEWS_DT":"2022-08-03T18:35:29.043","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Further to our communication dated 29th July 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed written transcript of the earnings call held on 28th July 2022 at 5.00 p.m.\r\nFurther, written transcript has been uploaded on the Company's website and can be accessed through the link:\r\nhttp://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ1(Apr-Jun)2022-23.pdf\r\nThis ....","SCRIP_CD":532331,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"7dccf0c6-431c-435b-8830-eb737f332061.pdf","NEWS_DT":"2022-05-14T13:09:18.517","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 10th May 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsC allTranscriptQ4(Jan-Mar)2021-22.pdf","SCRIP_CD":532331,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"3ae34c56-60dc-4710-858a-646de80fce56.pdf","NEWS_DT":"2022-02-04T14:26:00.73","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Further to our communication dated 31st January 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 31st January 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link:\r\nhttp://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ3(Oct-Dec)2021-22.pdf\r\n\r\nThis is for your information and records please.","SCRIP_CD":532331,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]